X-153700962-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001256447.2(BCAP31):c.716G>A(p.Gly239Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000913 in 1,205,017 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001256447.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BCAP31 | NM_001256447.2 | c.716G>A | p.Gly239Asp | missense_variant | 8/8 | ENST00000345046.12 | |
BCAP31 | NM_001139457.2 | c.917G>A | p.Gly306Asp | missense_variant | 8/8 | ||
BCAP31 | NM_001139441.1 | c.716G>A | p.Gly239Asp | missense_variant | 8/8 | ||
BCAP31 | NM_005745.8 | c.716G>A | p.Gly239Asp | missense_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BCAP31 | ENST00000345046.12 | c.716G>A | p.Gly239Asp | missense_variant | 8/8 | 1 | NM_001256447.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000898 AC: 1AN: 111369Hom.: 0 Cov.: 23 AF XY: 0.0000298 AC XY: 1AN XY: 33581
GnomAD3 exomes AF: 0.00000574 AC: 1AN: 174163Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 60041
GnomAD4 exome AF: 0.00000914 AC: 10AN: 1093648Hom.: 0 Cov.: 30 AF XY: 0.00000834 AC XY: 3AN XY: 359838
GnomAD4 genome AF: 0.00000898 AC: 1AN: 111369Hom.: 0 Cov.: 23 AF XY: 0.0000298 AC XY: 1AN XY: 33581
ClinVar
Submissions by phenotype
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory of genome editing, Research Centre for Medical Genetics | Sep 22, 2023 | PM2, PP1, PP3 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Dec 20, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3B. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with deafness, dystonia, and cerebral hypomyelination, (MIM#300475). (I) 0109 - This gene is associated with X-linked recessive disease. Heterozygous females are both asymptomatic, or affected with hearing loss, intellectual disability and/or liver disease (PMID: 33603160). (I) 0200 - Variant is predicted to result in a missense amino acid change from glycine to aspartic acid. (I) 0253 - This variant is hemizygous. (I) 0304 - Variant is present in gnomAD (v2, v3) <0.01 (1 heterozygote, 0 homozygotes, 1 hemizygote). (SP) 0503 - Missense variant consistently predicted to be tolerated by multiple in silico tools or not conserved in placental mammals with a minor amino acid change. (SB) 0600 - Variant is located in the annotated Bap31_Bap29_C domain (NCBI conserved domain). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0809 - Previous evidence of pathogenicity for this variant is inconclusive. This variant has been reported as a VUS (ClinVar), observed in an individual with movement disorders (Westmead), and maternally inherited in a hemizygous individual with delayed motor development, hearing loss, microcephaly and dysmorphic features (PMID: 35887114). (I) 1007 - No published functional evidence has been identified for this variant. (I) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 04, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 239 of the BCAP31 protein (p.Gly239Asp). This variant is present in population databases (no rsID available, gnomAD 0.001%). This missense change has been observed in individual(s) with BCAP31-related conditions (PMID: 35887114). ClinVar contains an entry for this variant (Variation ID: 1347813). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at